| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Achieve Life Sciences, Inc. (ACHV) has 14 insiders with recent SEC Form 4 filings, including 4 buys and 6 sells. ACHV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.80M | $8.63M | - | |
| Dir | 315.1K | $1.51M | - | |
| Other | 250.0K | $1.20M | - | |
| Pres | 143.2K | $686.0K | - | |
| CFO | 127.9K | $612.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2025 | Stewart Richard Alistair48 | Chief Executive Officer | Sale+OE | 129,501 | $2.92 | $378,142.92 | -36.1% | +47.4% | - | |
| Sep 18, 2025 | Oki Mark K | Chief Financial Officer | Sale+OE | 50,060 | $2.92 | $146,175.20 | -28.1% | +47.4% | - | |
| Sep 4, 2025 | King Thomas Braxton | Director | Sale+OE | 139,858 | $2.77 | $387,406.66 | -30.7% | +74.9% | - | |
| Sep 4, 2025 | Jacobs Cindy | President &CMO | Sale+OE | 27,629 | $2.77 | $76,532.33 | -19.3% | +74.9% | - | |
| Sep 4, 2025 | Xinos Jaime | Chief Commercial Officer | Sale+OE | 20,854 | $2.77 | $57,765.58 | -21.9% | +74.9% | - | |
| Sep 4, 2025 | Wan Jerry | Principal Accounting Officer | Sale+OE | 14,070 | $2.77 | $38,973.90 | -30.1% | +74.9% | - | |
| Mar 17, 2025 | Oki Mark K | Chief Financial Officer | Buy | 10,000 | $2.89 | $28,887.00 | New | +6.5% | +46.0% | |
| Mar 17, 2025 | Stewart Richard Alistair48 | Chieve Executive Officer | Buy | 10,000 | $2.86 | $28,598.00 | +19.7% | +6.5% | +46.0% | |
| Mar 4, 2024 | Stewart Richard Alistair48 | Executive Chairman | Buy | 10,000 | $4.59 | $45,850.00 | +35.1% | +17.9% | -34.2% | |
| Mar 4, 2024 | Bencich John45 | CEO | Buy | 10,000 | $4.59 | $45,850.00 | +15.0% | +17.9% | -34.2% |